mesalamine has been researched along with E coli Infections in 3 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The purpose of the present study was to investigate the effects of mesalazine, and metronidazole-gentamicin combination, on bacterial translocation in an animal colitis model." | 7.72 | Effect of mesalazine, metronidazole and gentamicin on bacterial translocation in experimental colitis. ( Aydogan, H; Gulec, B; Kilinc, M; Kozak, O; Ozcan, A; Pekcan, M; Yigit, T; Yigitler, C, 2004) |
| " The purpose of the present study was to investigate the effects of mesalazine, and metronidazole-gentamicin combination, on bacterial translocation in an animal colitis model." | 3.72 | Effect of mesalazine, metronidazole and gentamicin on bacterial translocation in experimental colitis. ( Aydogan, H; Gulec, B; Kilinc, M; Kozak, O; Ozcan, A; Pekcan, M; Yigit, T; Yigitler, C, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Park, SK | 1 |
| Kang, SB | 1 |
| Kim, S | 1 |
| Kim, TO | 1 |
| Cha, JM | 1 |
| Im, JP | 1 |
| Choi, CH | 1 |
| Kim, ES | 1 |
| Seo, GS | 1 |
| Eun, CS | 1 |
| Han, DS | 1 |
| Park, DI | 1 |
| Stange, EF | 1 |
| von Bünau, R | 1 |
| Erhardt, A | 1 |
| Yigitler, C | 1 |
| Gulec, B | 1 |
| Aydogan, H | 1 |
| Ozcan, A | 1 |
| Kilinc, M | 1 |
| Yigit, T | 1 |
| Kozak, O | 1 |
| Pekcan, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effect of Mutaflor in Patients With Mild-to-moderate Ulcerative Colitis on 5-ASA Treatment.[NCT04969679] | Phase 4 | 134 participants (Actual) | Interventional | 2018-03-16 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for mesalamine and E coli Infections
| Article | Year |
|---|---|
Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis.
Topics: Colitis, Ulcerative; Double-Blind Method; Escherichia coli; Escherichia coli Infections; Humans; Mes | 2022 |
2 other studies available for mesalamine and E coli Infections
| Article | Year |
|---|---|
Ulcerative colitis-Maintanance of Remission With the Probiotic Escherichia coli Strain Nissle 1917.
Topics: Colitis, Ulcerative; Escherichia coli; Escherichia coli Infections; Humans; Mesalamine; Probiotics | 2021 |
Effect of mesalazine, metronidazole and gentamicin on bacterial translocation in experimental colitis.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Translocation; Co | 2004 |